Maternal Use of Proton Pump Inhibitors (PPI) during Pregnancy Is Associated with an Increased Risk for Cardiac Birth Defects: Analysis of 208,951 Pregnancies from the THIN Database

May-10

Gastroenterology Gynecology and Obstetrics Paediatrics Pharmacoepidemiology

AUTHORS : Dr Yu-Xiao Yang, MD, MSCE, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 423 Guardian Drive, 733 Blockley Hall, Philadelphia, Pennsylvania 19010, USA – Email: yangy@pennmedicine.upenn.edu – Profile: https://www.med.upenn.edu/apps/faculty/index.php/g275/p18504

JOURNAL : Gastroenterology

REFERENCE: 138(5):S63

DOI : 10.1016/S0016-5085(10)60285-5

Maternal Use of Proton Pump Inhibitors (PPI) during Pregnancy Is Associated with an Increased Risk for Cardiac Birth Defects: Analysis of 208,951 Pregnancies from the THIN Database

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Colonic Diverticulosis and Uncomplicated Diverticulitis Are Associated With a Lower Not Higher Risk of Mortality When Confounding Factors Are Held Constant

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement